Target intelligence / Profile preview

DNA (calicheamicin-binding site)

Molecular classification
Other (non-protein, macromolecular structure)
01

Overview

The induction of DNA double-strand breaks by calicheamicin occurs when the antitumor antibiotic calicheamicin, often employed as a cytotoxic payload in ADCs, binds specifically in the minor groove of DNA. Following activation (often by chemical reduction within the cell), calicheamicin undergoes Bergman cyclization, forming a highly reactive diradical species that abstracts hydrogens from the DNA backbone, ultimately causing double-strand scission. This is a dominant mechanism for the cell-killing effect of calicheamicin-derived ADCs and underlies the efficacy (and toxicity) of these agents. \n\nNote: \nThis entry is not a canonical individual target (such as a protein or conventional receptor) but instead denotes a DNA structural motif (the minor groove) and a mechanism by which DNA integrity is compromised using an external agent (calicheamicin). As such, the entry is best treated as a descriptor of a mechanism, not a molecular drug target per standard pharmacological nomenclature.

Other names
DNA minor groove (calicheamicin binding site)DNA double-strand breakDSB site
02

Mechanism of action

DNA minor groove binding by calicheamicin triggers Bergman cyclization, generating diradicals that abstract hydrogens from the DNA deoxyribose, causing double-strand breaks\nThe double-strand breaks result in apoptosis of the targeted cell

03

Biological functions

Genetic information storageTarget for cytotoxic agents
04

Disease associations

Cancer (as a target for chemotherapeutic agent-induced damage)Other (context-dependent)
05

Safety considerations

Non-specific DNA damage leading to toxicity in normal cellsMyelosuppressionPotential secondary malignancies as a result of DNA damage
06

Interacting drugs

Calicheamicin

2 more in the full profile.

07

Biomarkers

Phosphorylated H2AX (γ-H2AX, marker of DNA DSBs)

Beyond the preview

Go deeper on DNA (calicheamicin-binding site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA (calicheamicin-binding site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call